Current Research on Obesity

Worldwide, at least 2.8 million people die annually as a results of being overweight or fat, and an estimated 35.8 million (2.3%) of world DALYs are caused by overweight or obesity. Overweight and fatness result in adverse metabolic effects on blood pressure, sterol, triglycerides and hypoglycemic agent resistance. Risks of coronary heart disease, cerebrovascular accident and type 2 diabetes increase steady with increasing body mass index (BMI), a measure of weight relative to height. Raised body mass index also will increase the chance of cancer of the breast, colon, prostate, mucous membrane, excretory organ and gall bladder. Mortality rates increase with increasing overweight, as degrees of measured by body mass index. The prevalence of overweight and fatness were highest within the WHO Regions of the Americas (62% for overweight in each sexes, and twenty sixth for obesity) and lowest within the WHO Region for South East Asia (14% overweight in both sexes and three for obesity).

 

  • Use of Nano Technology
  • Drug treatments and devices for Obesity
  • Nutritional Genomics
  • Probiotics for human health

Related Conference of Current Research on Obesity

June 10-11, 2024

24th Global Summit on Obesity

Dubai, UAE
June 27-28, 2024

20th Euro Obesity and Endocrinology Congress

London, UK
August 29-30, 2024

18th International Conference on Obesity Medicine

Helsinki, Finland
November 28-29, 2024

25th Annual Meet on Obesity and Diet

Bali, Indonesia

Current Research on Obesity Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in